Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Bicknell laboratory, |
RCV001527367 | SCV001738347 | pathogenic | Meier-Gorlin syndrome | criteria provided, single submitter | research | ||
Illumina Laboratory Services, |
RCV003314693 | SCV004014692 | likely pathogenic | Microcephaly, short stature, and limb abnormalities | 2023-05-05 | criteria provided, single submitter | clinical testing | The DONSON c.494T>C (p.Phe165Ser) missense variant has been reported in a compound heterozygous state in one individual with Meier-Gorlin syndrome (PMID: 31784481). This variant is reported in the Genome Aggregation Database in 5 alleles at a frequency of 0.000174 in the African/African American population (version 3.1.2), which is consistent with estimates of disease prevalence in this population. A functional study conducted in human cell lines demonstrated that this variant impairs normal subcellular localization (PMID: 31784481). Multiple lines of computational evidence suggest this variant may impact the gene or gene product. Based on the evidence, the c.494T>C (p.Phe165Ser) variant is classified as likely pathogenic for microcephaly, short stature, and limb abnormalities. |